Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
Eiger has expanded its licensing agreement with Merck to include rights to develop the investigational farnesyltransferase inhibitor lonafarnib for the treatment of Hutchinson-Gilford Progeria Syndrome.
read more
Wednesday, September 13, 2023
Eisai announced that it has established a digital business company Theoria technologies which will accelerate the development of a dementia ecosystem. Theoria technologies is a wholly owned subsidiary of Eisai.
read more
Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has announced the immediate appointment of Kirk Shepard, MD, as Senior Vice President, Global Medical Affairs of the Oncology Business Group. Dr. Shepard will be responsible for ...
read more
Wednesday, October 26, 2016
Eisai Inc. and the Oklahoma Medical Research Foundation (OMRF) have formed a research collaboration to study the autoimmune disease lupus.
read more
Friday, September 06, 2019
Elekta has signed a distribution agreement with DOSIsoft, a company that offers patient-specific QA software, to be the sole distributor of three DOSIsoft patient QA products
read more
Element Materials Technology has acquired Arch Sciences Group, a leading provider of analytical services and laboratory solutions in pharmaceuticals. As well as marking Element’s entry into the European pharmaceutical market, the move means that the ...
read more
Tuesday, February 09, 2021
Element has acquired a pharmaceutical analytical testing company, Avomeen, strengthening the Group’s Life Sciences business unit in North America.
read more
Wednesday, September 08, 2021
Based in Midland, Michigan, Impact Analytical operates in the pharmaceutical, medical device, consumer product and specialty chemicals segments, with a strong presence in extractables and leachables. The business recently moved into the bio-...
read more
Thursday, October 14, 2021
Element Materials Technology (Element) has acquired Nanosyn, a full-service pharmaceuticals contract development and manufacturing organization, significantly strengthening Element’s offering for pharmaceutical and biopharmaceutical customers in ...
read more
Element Materials Technology has acquired pharmaceutical testing business, Analytical Lab Group (ALG) from Thompson Street Capital Partners.
read more
Tuesday, February 04, 2025
Eleva and 3PBIOVIAN announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva’s technology platform.
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
Elevation Oncology and US Oncology announced a collaboration to utilize the US Oncology Research STAR program for patient enrollment in the registration-enabling Phase 2 CRESTONE study.
read more
ABEC announced it will deliver multiple Custom Single Run (CSR®) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.
read more